Home/Filings/4/0001610717-23-000044
4//SEC Filing

Moretti August J 4

Accession 0001610717-23-000044

CIK 0001650648other

Filed

May 15, 8:00 PM ET

Accepted

May 16, 8:52 PM ET

Size

6.7 KB

Accession

0001610717-23-000044

Insider Transaction Report

Form 4
Period: 2023-05-15
Moretti August J
See Remarks
Transactions
  • Exercise/Conversion

    Common Stock

    2023-05-15$9.41/sh+3,000$28,23011,045 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-05-153,000217,060 total
    Exercise: $9.41Exp: 2029-03-19Common Stock (3,000 underlying)
Footnotes (2)
  • [F1]Reflects 1,450 shares of the Issuer's common stock purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt from Rule 16b-3.
  • [F2]The option is fully vested and exercisable

Documents

1 file

Issuer

4D Molecular Therapeutics, Inc.

CIK 0001650648

Entity typeother

Related Parties

1
  • filerCIK 0001344412

Filing Metadata

Form type
4
Filed
May 15, 8:00 PM ET
Accepted
May 16, 8:52 PM ET
Size
6.7 KB